Clin2
NCT07528196Worth exploringNot yet recruiting

Herbal medicine for acute respiratory distress syndrome

Acute Respiratory Distress Syndrome (ARDS)

Part of Lungs & breathing clinical trials.

This study tests whether a traditional Chinese herbal mixture, called Xuanbai Shengmai decoction, can help people with acute respiratory distress syndrome (ARDS), a serious lung condition. The goal is to see if this herbal treatment improves breathing and recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
308 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You have been diagnosed with ARDS (a severe lung condition) within the last 48 hours.
  • You are between 18 and 85 years old.
  • You are not pregnant or breastfeeding.
  • You do not have severe stomach or bowel problems that would prevent taking the medicine through a tube or by mouth.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07186140Not yet recruiting
Study of acute respiratory distress syndrome: features and outcomes

This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.

Seoul
NCT07395076Recruiting
Study of immune causes of acute respiratory distress

This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.

Paris
NCT06703073Recruiting· Phase 2
Testing new treatments for acute respiratory distress syndrome (ARDS)

This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.

Birmingham, Alabama
NCT07208591Recruiting· Phase 3
Test of an experimental drug for severe viral lung infection (ARDS)

This study tests an experimental drug (STSA-1002) for people with severe breathing problems caused by a viral infection. It aims to see if the drug can help improve oxygen levels and reduce the need for a breathing machine.

Beijing, Beijing Municipality
NCT07403032Not yet recruiting
Herbal treatment for COPD flare-ups

This trial tests a traditional Chinese herbal formula, modified Ma Xing Shi Gan decoction, as an add-on treatment for people hospitalized with a sudden worsening (acute exacerbation) of chronic obstructive pulmonary disease (COPD), specifically when symptoms suggest a pattern called phlegm-heat. The goal is to see if this herbal treatment helps ease symptoms and improve recovery.

NCT07286409Not yet recruiting
Breathing treatments for acute respiratory distress syndrome

This study tests three inhaled medicines—furosemide, heparin, and salt water—to see if they help people on breathing machines with a severe lung condition called ARDS. It may improve breathing and recovery.

Tanta, El Gharbyia

Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.